India is projected to become world’s third-largest economy by 2027, offering opportunities for medical device companies due to its demographics and healthcare demand. China’s market faces challenges from U.S. tensions and procurement policies.
Life expectancy in India has increased by 10 years, reaching 70.8 years. Rising affluence has increased chronic diseases. The medical device market is expected to grow from $12B (2022) to $50B (2030) at 21% CAGR, higher than the global CAGR of 5%. India’s middle class is projected to double to 61% of population by 2046. Rising disposable income drives healthcare spending through out-of-pocket payments. India’s Tier 2+ cities show strong growth with 19% year-on-year income increase vs 6% in Tier 1 cities. These cities account for 64% of total surgeries, presenting expansion opportunities.
India presents growth opportunities but requires careful market navigation due to unique conditions.
According to an article in Medical Buyer , global device companies need specific strategies to navigate the Indian healthcare market:
- Companies should focus on Tier 1 cities for established markets and Tier 2 cities for growth potential, using a step-wise expansion approach.
- Strategic partnerships with corporate hospitals and selective top-tier government institutions can provide competitive advantages.
- Focus should be on medium-high income patients who can afford treatment. Digital engagement is crucial for reaching this segment.
- Understanding all stakeholders (nurses, technicians, financial coordinators) beyond physicians is crucial for product adoption.
Last updated: December 26th, 2025
